{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:32:40Z","timestamp":1788834760095,"version":"build-2803163510"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["SALUD-2010-C02"],"award-info":[{"award-number":["SALUD-2010-C02"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["salud 2010"],"award-info":[{"award-number":["salud 2010"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007774","name":"Instituto de Ciencia y Tecnolog\u00eda del Distrito Federal","doi-asserted-by":"publisher","award":["2010"],"award-info":[{"award-number":["2010"]}],"id":[{"id":"10.13039\/100007774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The formation of amyloid oligomers and fibrils of the human islet amyloid polypeptide (hIAPP) has been linked with \u03b2- cell failure and death which causes the onset, progression, and comorbidities of diabetes. We begin to unpack the aggregation-oligomerization-fibrillization process of these oligomers taken from sera of pediatric patients. The naturally occurring or\u00a0real hIAPP (not synthetic) amyloid oligomers (RIAO) were successfully isolated, we demonstrated the presence of homo (dodecamers, hexamers, and trimers) and hetero-RIAO, as well as several biophysical characterizations which allow us to learn from the real phenomenon taking place. We found that the aggregation\/oligomerization process is active in the sera and showed that it happens very fast. The RIAO can form fibers and react with anti-hIAPP and anti-amyloid oligomers antibodies. Our results opens the epistemic horizon and reveal real differences between the four groups (Controls vs obesity, T1DM or T2DM) accelerating the process of understanding and discovering novel and more efficient prevention, diagnostic, transmission and therapeutic pathways.<\/jats:p>","DOI":"10.1038\/s41598-019-54570-8","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T11:02:42Z","timestamp":1575543762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Unpacking the aggregation-oligomerization-fibrillization process of naturally-occurring hIAPP amyloid oligomers isolated directly from sera of children with obesity or diabetes mellitus"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7297-4689","authenticated-orcid":false,"given":"Myriam M.","family":"Altamirano-Bustamante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly F.","family":"Altamirano-Bustamante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateo","family":"Larralde-Laborde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2708-573X","authenticated-orcid":false,"given":"Reyna","family":"Lara-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Leyva-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eulalia","family":"Garrido-Maga\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Felipe","family":"Jim\u00e9nez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Revilla-Monsalve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perla","family":"Altamirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Calzada-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,5]]},"reference":[{"key":"54570_CR1","doi-asserted-by":"publisher","unstructured":"Sontag, E. M., Samant, R. S. & Frydman, J. Mechanisms and Functions of Spatial Protein Quality Control., https:\/\/doi.org\/10.1146\/annurev-biochem (2017).","DOI":"10.1146\/annurev-biochem"},{"key":"54570_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"F Chiti","year":"2017","unstructured":"Chiti, F. et al. Structural Studies of Amyloid Proteins at the Molecular Level. Annu. Rev. Biochem. 86, 193\u2013224 (2017).","journal-title":"Annu. Rev. Biochem."},{"key":"54570_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev-biochem-061516-045104","volume":"86","author":"DS Eisenberg","year":"2017","unstructured":"Eisenberg, D. S. & Sawaya, M. R. Structural Studies of Amyloid Proteins at the Molecular Level. Annu. Rev. Biochem. 86, 69\u201395 (2017).","journal-title":"Annu. Rev. Biochem."},{"key":"54570_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev-biochem-061516-044908","volume":"86","author":"I Dikic","year":"2017","unstructured":"Dikic, I. Proteasomal and Autophagic Degradation Systems. Annu. Rev. Biochem. 86, 193\u2013224 (2017).","journal-title":"Annu. Rev. Biochem."},{"key":"54570_CR5","doi-asserted-by":"crossref","unstructured":"Knowles, T. P., Vendruscolo, M. & Dobson, C. M. The amyloid state and its association with protein misfolding diseases. Nat.Rev.Mol.Cell Biol. 15, 384\u2013396 (2014).","DOI":"10.1038\/nrm3810"},{"issue":"2-3","key":"54570_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S0014-5793(01)02486-3","volume":"498","author":"Claudio Soto","year":"2001","unstructured":"Soto, C. Protein misfolding and disease; protein refolding and therapy. FEBS Lett. 498, 204\u2013207 (2001).","journal-title":"FEBS Letters"},{"key":"54570_CR7","doi-asserted-by":"crossref","unstructured":"Invernizzi, G., Papaleo, E., Sabate, R. & Ventura, S. Protein aggregation: mechanisms and functional consequences. Int.J.Biochem.Cell Biol. 44, 1541\u20131554 (2012).","DOI":"10.1016\/j.biocel.2012.05.023"},{"key":"54570_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sbi.2009.01.006","volume":"19","author":"V Daggett","year":"2009","unstructured":"Daggett, V. & Fersht, A. R. Protein folding and binding: moving into unchartered territory. Curr. Opin. Struct. Biol. 19, 1\u20132 (2009).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"54570_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3390\/molecules23010079","volume":"23","author":"M Avila-Vazquez","year":"2017","unstructured":"Avila-Vazquez, M., Altamirano-Bustamante, N. & Altamirano-Bustamante, M. Amyloid Biomarkers in Conformational Diseases at Face Value: A Systematic Review. Molecules 23, 79 (2017).","journal-title":"Molecules"},{"issue":"11","key":"54570_CR10","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.tcb.2005.09.005","volume":"15","author":"Robin W. Carrell","year":"2005","unstructured":"Carrell, R. W. Cell toxicity and conformational disease. Trends Cell Biol. 15, 574\u2013580 (2005).","journal-title":"Trends in Cell Biology"},{"key":"54570_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0140-6736(97)02073-4","volume":"350","author":"RW Carrell","year":"1997","unstructured":"Carrell, R. W. & Lomas, D. A. Conformational disease. Lancet 350, 134\u2013138 (1997).","journal-title":"Lancet"},{"key":"54570_CR12","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nature03680","volume":"435","author":"R Nelson","year":"2005","unstructured":"Nelson, R. et al. Structure of the cross-beta spine of amyloid-like fibrils. Nature 435, 773\u2013778 (2005).","journal-title":"Nature"},{"key":"54570_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nature20416","volume":"539","author":"R Riek","year":"2016","unstructured":"Riek, R. & Eisenberg, D. S. The activities of amyloids from a structural perspective. Nature 539, 227\u2013235 (2016).","journal-title":"Nature"},{"key":"54570_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1152\/physrev.00042.2009","volume":"91","author":"P Westermark","year":"2011","unstructured":"Westermark, P., Andersson, A. & Westermark, G. T. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol Rev. 91, 795\u2013826 (2011).","journal-title":"Physiol Rev."},{"key":"54570_CR15","doi-asserted-by":"publisher","unstructured":"An, S. S. & Jeong, H. R. Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2&nbsp;diabetes mellitus. Clin. Interv. Aging 1873, https:\/\/doi.org\/10.2147\/cia.s95297 (2015).","DOI":"10.2147\/cia.s95297"},{"key":"54570_CR16","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1016\/j.bbamem.2011.06.012","volume":"1808","author":"RPR Nanga","year":"2011","unstructured":"Nanga, R. P. R., Brender, J. R., Vivekanandan, S. & Ramamoorthy, A. Structure and membrane orientation of IAPP in its natively amidated form at physiological pH in a membrane environment. Biochim. Biophys. Acta - Biomembr. 1808, 2337\u20132342 (2011).","journal-title":"Biochim. Biophys. Acta - Biomembr."},{"key":"54570_CR17","doi-asserted-by":"publisher","first-page":"12689","DOI":"10.1021\/bi8014357","volume":"47","author":"RPR Nanga","year":"2008","unstructured":"Nanga, R. P. R., Brender, J. R., Xu, J., Veglia, G. & Ramamoorthy, A. Structures of rat and human islet amyloid polypeptide IAPP1-19 in micelles by NMR spectroscopy. Biochemistry 47, 12689\u201312697 (2008).","journal-title":"Biochemistry"},{"key":"54570_CR18","doi-asserted-by":"publisher","first-page":"8252","DOI":"10.1021\/ja9010095","volume":"131","author":"RPR Nanga","year":"2009","unstructured":"Nanga, R. P. R. et al. Three-dimensional structure and orientation of rat islet amyloid polypeptide protein in a membrane environment by solution NMR spectroscopy. J. Am. Chem. Soc. 131, 8252\u201361 (2009).","journal-title":"J. Am. Chem. Soc."},{"key":"54570_CR19","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1021\/jp511758w","volume":"119","author":"JR Brender","year":"2015","unstructured":"Brender, J. R. et al. Probing the sources of the apparent irreproducibility of amyloid formation: Drastic changes in kinetics and a switch in mechanism due to micellelike oligomer formation at critical concentrations of IAPP. J. Phys. Chem. B 119, 2886\u20132896 (2015).","journal-title":"J. Phys. Chem. B"},{"key":"54570_CR20","doi-asserted-by":"publisher","first-page":"106239","DOI":"10.1016\/j.bpc.2019.106239","volume":"254","author":"M Beck Erlach","year":"2019","unstructured":"Beck Erlach, M., Kalbitzer, H. R., Winter, R. & Kremer, W. The pressure and temperature perturbation approach reveals a whole variety of conformational substates of amyloidogenic hIAPP monitored by 2D NMR spectroscopy. Biophys. Chem. 254, 106239 (2019).","journal-title":"Biophys. Chem."},{"key":"54570_CR21","doi-asserted-by":"crossref","unstructured":"Gao, M. & Winter, R. The Effects of Lipid Membranes, Crowding and Osmolytes on the Aggregation, and Fibrillation Propensity of Human IAPP. J. Diabetes Res. 2015 (2015).","DOI":"10.1155\/2015\/849017"},{"key":"54570_CR22","doi-asserted-by":"crossref","unstructured":"Tomasello, M. F. & Sinopoli, A. On the Environmental Factors Affecting the Structural and Cytotoxic Properties of IAPP Peptides. Journal of Diabetes Research 2015, no pagination (2015).","DOI":"10.1155\/2015\/918573"},{"key":"54570_CR23","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1021\/jz5001775","volume":"5","author":"HR Patel","year":"2014","unstructured":"Patel, H. R., Pithadia, A. S., Brender, J. R., Fierke, C. A. & Ramamoorthy, A. In Search of Aggregation Pathways of IAPP and Other Amyloidogenic Proteins: Finding Answers through NMR Spectroscopy. J. Phys. Chem. Lett. 5, 1864\u201370 (2014).","journal-title":"J. Phys. Chem. Lett."},{"key":"54570_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.19273","volume":"6","author":"P Krotee","year":"2017","unstructured":"Krotee, P. et al. Atomic structures of fibrillar segments of hIAPP suggest tightly mated \u03b2-sheets are important for cytotoxicity. Elife 6, 1\u201326 (2017).","journal-title":"Elife"},{"key":"54570_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.31226","volume":"6","author":"DC Rodriguez Camargo","year":"2017","unstructured":"Rodriguez Camargo, D. C. et al. Stabilization and structural analysis of a membrane-associated hIAPP aggregation intermediate. Elife 6, 1\u201322 (2017).","journal-title":"Elife"},{"key":"54570_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11776-y","volume":"7","author":"E Leyva-Garc\u00eda","year":"2017","unstructured":"Leyva-Garc\u00eda, E. et al. Novel insight into streptozotocin-induced diabetic rats from the protein misfolding perspective. Sci. Rep. 7, 11552 (2017).","journal-title":"Sci. Rep."},{"key":"54570_CR27","doi-asserted-by":"publisher","first-page":"8908","DOI":"10.1039\/c3cp44696d","volume":"15","author":"JR Brender","year":"2013","unstructured":"Brender, J. R. et al. Membrane disordering is not sufficient for membrane permeabilization by islet amyloid polypeptide: studies of IAPP(20\u201329) fragments. Phys. Chem. Chem. Phys. 15, 8908\u201315 (2013).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"54570_CR28","doi-asserted-by":"publisher","first-page":"12680","DOI":"10.1021\/bi801427c","volume":"47","author":"JR Brender","year":"2008","unstructured":"Brender, J. R., Hartman, K., Reid, K. R., Kennedy, R. T. & Ramamoorthy, A. A single mutation in the nonamyloidogenic region of islet amyloid polypeptide greatly reduces toxicity. Biochemistry 47, 12680\u201312688 (2008).","journal-title":"Biochemistry"},{"key":"54570_CR29","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1021\/ar200189b","volume":"45","author":"JR Brender","year":"2012","unstructured":"Brender, J. R., Salamekh, S. & Ramamoorthy, A. Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective. Acc. Chem. Res. 45, 454\u2013462 (2012).","journal-title":"Acc. Chem. Res."},{"key":"54570_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"F Chiti","year":"2017","unstructured":"Chiti, F. & Dobson, C. M. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. Annu. Rev. Biochem. 86, 27\u201368 (2017).","journal-title":"Annu. Rev. Biochem."},{"key":"54570_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bpc.2018.12.002","volume":"245","author":"MB Divakara","year":"2019","unstructured":"Divakara, M. B. et al. Molecular mechanisms for the destabilization of model membranes by islet amyloid polypeptide. Biophys. Chem. 245, 34\u201340 (2019).","journal-title":"Biophys. Chem."},{"key":"54570_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ijbiomac.2019.06.050","volume":"136","author":"A Chaari","year":"2019","unstructured":"Chaari, A. & Ladjimi, M. Human islet amyloid polypeptide (hIAPP) aggregation in type 2 diabetes: Correlation between intrinsic physicochemical properties of hIAPP aggregates and their cytotoxicity. Int. J. Biol. Macromol. 136, 57\u201365 (2019).","journal-title":"Int. J. Biol. Macromol."},{"key":"54570_CR33","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/1097-0282(2001)60:6<438::AID-BIP10182>3.0.CO;2-A","volume":"60","author":"A Kapurniotu","year":"2001","unstructured":"Kapurniotu, A. Amyloidogenicity and cytotoxicity of islet amyloid polypeptide. Biopolymers 60, 438\u2013459 (2001).","journal-title":"Biopolymers"},{"key":"54570_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/srep04267","volume":"4","author":"Y Bram","year":"2014","unstructured":"Bram, Y. et al. Apoptosis induced by islet amyloid polypeptide soluble oligomers is neutralized by diabetes-associated specific antibodies. Sci. Rep. 4, 4267 (2014).","journal-title":"Sci. Rep."},{"key":"54570_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-93","volume":"8","author":"AC Klaver","year":"2011","unstructured":"Klaver, A. C. et al. ELISA measurement of specific non-antigen-bound antibodies to A\u03b21-42 monomer and soluble oligomers in sera from Alzheimer\u2019s disease, mild cognitively impaired, and noncognitively impaired subjects. J. Neuroinflammation 8, 93 (2011).","journal-title":"J. Neuroinflammation"},{"key":"54570_CR36","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1016\/j.febslet.2013.09.006","volume":"587","author":"JR Peinado","year":"2013","unstructured":"Peinado, J. R., Sami, F., Rajpurohit, N. & Lindberg, I. Blockade of islet amyloid polypeptide fibrillation and cytotoxicity by the secretory chaperones 7B2 and proSAAS. FEBS Lett. 587, 3406\u201311 (2013).","journal-title":"FEBS Lett."},{"key":"54570_CR37","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0140-6736(87)90825-7","volume":"2","author":"A Clark","year":"1987","unstructured":"Clark, A. et al. Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet (London, England) 2, 231\u20134 (1987).","journal-title":"Lancet (London, England)"},{"key":"54570_CR38","doi-asserted-by":"publisher","first-page":"R121","DOI":"10.1530\/JME-17-0105","volume":"59","author":"D Raleigh","year":"2017","unstructured":"Raleigh, D., Zhang, X., Hastoy, B. & Clark, A. The \u03b2-cell assassin: IAPP cytotoxicity. J. Mol. Endocrinol. 59, R121\u2013R140 (2017).","journal-title":"J. Mol. Endocrinol."},{"key":"54570_CR39","doi-asserted-by":"crossref","unstructured":"Pithadia, A., Brender, J. R., Fierke, C. A. & Ramamoorthy, A. Inhibition of IAPP Aggregation and Toxicity by Natural Products and Derivatives. J. Diabetes Res. 2016 (2016).","DOI":"10.1155\/2016\/2046327"},{"issue":"9","key":"54570_CR40","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.bbamem.2018.03.012","volume":"1860","author":"Michele F.M. Sciacca","year":"2018","unstructured":"Sciacca, M. F. M. et al. A blend of two resveratrol derivatives abolishes hIAPP amyloid growth and membrane damage. Biochim. Biophys. Acta - Biomembr., https:\/\/doi.org\/10.1016\/j.bbamem.2018.03.012 (2018).","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"key":"54570_CR41","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed, R. Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis. Science (80-.). 300, 486\u2013489 (2003).","journal-title":"Science (80-.)."},{"key":"54570_CR42","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S0076-6879(06)13017-7","volume":"413","author":"R Kayed","year":"2006","unstructured":"Kayed, R. & Glabe, C. G. Conformation-dependent anti-amyloid oligomer antibodies. Methods Enzymol. 413, 326\u2013344 (2006).","journal-title":"Methods Enzymol."},{"key":"54570_CR43","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1039\/c3cc40383a","volume":"49","author":"JR Brender","year":"2013","unstructured":"Brender, J. R. et al. Zinc stabilization of prefibrillar oligomers of human islet amyloid polypeptide. Chem. Commun. (Camb). 49, 3339\u201341 (2013).","journal-title":"Chem. Commun. (Camb)."},{"key":"54570_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.46574","volume":"8","author":"TK Karamanos","year":"2019","unstructured":"Karamanos, T. K. et al. Structural mapping of oligomeric intermediates in an amyloid assembly pathway. Elife 8, 1\u201332 (2019).","journal-title":"Elife"},{"key":"54570_CR45","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1016\/j.bbamem.2007.07.001","volume":"1768","author":"JR Brender","year":"2007","unstructured":"Brender, J. R., D\u00fcrr, U. H. N., Heyl, D., Budarapu, M. B. & Ramamoorthy, A. Membrane fragmentation by an amyloidogenic fragment of human Islet Amyloid Polypeptide detected by solid-state NMR spectroscopy of membrane nanotubes. Biochim. Biophys. Acta - Biomembr. 1768, 2026\u20132029 (2007).","journal-title":"Biochim. Biophys. Acta - Biomembr."},{"key":"54570_CR46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.trsl.2008.10.009","volume":"153","author":"H-LL Zhao","year":"2009","unstructured":"Zhao, H.-L. L. et al. Amyloid oligomers in diabetic and nondiabetic human pancreas. Transl. Res. 153, 24\u201332 (2009).","journal-title":"Transl. Res."},{"key":"54570_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2017.01.017","volume":"131","author":"C Giacomelli","year":"2017","unstructured":"Giacomelli, C., Daniele, S. & Martini, C. Potential biomarkers and novel pharmacological targets in protein aggregation-related neurodegenerative diseases. Biochem. Pharmacol. 131, 1\u201315 (2017).","journal-title":"Biochem. Pharmacol."},{"key":"54570_CR48","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.bpj.2010.09.070","volume":"100","author":"JR Brender","year":"2011","unstructured":"Brender, J. R. et al. Biphasic effects of insulin on islet amyloid polypeptide membrane disruption. Biophys. J. 100, 685\u2013692 (2011).","journal-title":"Biophys. J."},{"issue":"1","key":"54570_CR49","doi-asserted-by":"publisher","first-page":"129422","DOI":"10.1016\/j.bbagen.2019.129422","volume":"1864","author":"Li-Ping Gao","year":"2020","unstructured":"Gao, L.-P. et al. Fibrillation of human islet amyloid polypeptide and its toxicity to pancreatic \u03b2-cells under lipid environment. Biochim. Biophys. acta. Gen. Subj. 129422, https:\/\/doi.org\/10.1016\/j.bbagen.2019.129422 (2019).","journal-title":"Biochimica et Biophysica Acta (BBA) - General Subjects"},{"key":"54570_CR50","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.2337\/db07-0178","volume":"56","author":"S Casas","year":"2007","unstructured":"Casas, S. et al. Impairment of the ubiquitin-proteasome pathway is a downstream endoplasmic reticulum stress response induced by extracellular human islet amyloid polypeptide and contributes to pancreatic beta-cell apoptosis. Diabetes 56, 2284\u20132294 (2007).","journal-title":"Diabetes"},{"key":"54570_CR51","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1172\/JCI69866","volume":"124","author":"N Shigihara","year":"2014","unstructured":"Shigihara, N. et al. Human IAPP-induced pancreatic $\u03b2$ cell toxicity and its regulation by autophagy. J. Clin. Invest. 124, 3634\u20133644 (2014).","journal-title":"J. Clin. Invest."},{"key":"54570_CR52","doi-asserted-by":"publisher","unstructured":"Hogan, M. F. et al. RNA-seq-based identification of Star upregulation by islet amyloid formation. Protein Eng. Des. Sel., https:\/\/doi.org\/10.1093\/protein\/gzz022 (2019).","DOI":"10.1093\/protein\/gzz022"},{"key":"54570_CR53","doi-asserted-by":"crossref","unstructured":"Montemurro, C. et al. IAPP toxicity activates HIF1\u03b1\/PFKFB3 signaling delaying \u03b2-cell loss at the expense of \u03b2-cell function. Nat. Commun. 10 (2019).","DOI":"10.1038\/s41467-019-10444-1"},{"issue":"8","key":"54570_CR54","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/S2213-8587(19)30082-8","volume":"7","author":"Sylvia Kehlenbrink","year":"2019","unstructured":"Kehlenbrink, S. et al. The burden of diabetes and use of diabetes care in humanitarian crises in low-income and middle-income countries. lancet. Diabetes Endocrinol., https:\/\/doi.org\/10.1016\/S2213-8587(19)30082-8 (2019).","journal-title":"The Lancet Diabetes & Endocrinology"},{"key":"54570_CR55","doi-asserted-by":"crossref","unstructured":"Altamirano-Bustamante, N. et al. Economic family burden of metabolic control in children and adolescents with type 1 diabetes mellitus. J. Pediatr. Endocrinol. Metab. 21 (2008).","DOI":"10.1515\/JPEM.2008.21.12.1163"},{"key":"54570_CR56","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ebiom.2016.03.035","volume":"6","author":"U Sengupta","year":"2016","unstructured":"Sengupta, U., Nilson, A. N. & Kayed, R. The Role of Amyloid-\u03b2 Oligomers in Toxicity, Propagation, and Immunotherapy. EBioMedicine 6, 42\u201349 (2016).","journal-title":"EBioMedicine"},{"key":"54570_CR57","doi-asserted-by":"publisher","first-page":"9685","DOI":"10.1021\/jacs.8b05925","volume":"140","author":"AI Ilitchev","year":"2018","unstructured":"Ilitchev, A. I. et al. Hetero-oligomeric Amyloid Assembly and Mechanism: Prion Fragment PrP(106-126) Catalyzes the Islet Amyloid Polypeptide \u03b2-Hairpin. J. Am. Chem. Soc. 140, 9685\u20139695 (2018).","journal-title":"J. Am. Chem. Soc."},{"key":"54570_CR58","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5334\/irsp.82","volume":"30","author":"M Delacre","year":"2017","unstructured":"Delacre, M., Lakens, D. & Leys, C. Why Psychologists Should by Default Use Welch\u2019s t-test Instead of Student\u2019s t-test. Int. Rev. Soc. Psychol. 30, 92 (2017).","journal-title":"Int. Rev. Soc. Psychol."},{"key":"54570_CR59","first-page":"175","volume":"72","author":"PM Kroonenberg","year":"2018","unstructured":"Kroonenberg, P. M. & Verbeek, A. The Tale of Cochran\u2019s Rule: My Contingency Table has so Many Expected Values Smaller than 5. What Am I to Do? Am. Stat. 72, 175\u2013183 (2018).","journal-title":"What Am I to Do? Am. Stat."},{"key":"54570_CR60","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jmgm.2017.09.004","volume":"77","author":"P Patel","year":"2017","unstructured":"Patel, P., Parmar, K., Vyas, V. K., Patel, D. & Das, M. Combined in silico approaches for the identification of novel inhibitors of human islet amyloid polypeptide (hIAPP) fibrillation. J. Mol. Graph. Model. 77, 295\u2013310 (2017).","journal-title":"J. Mol. Graph. Model."},{"key":"54570_CR61","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00125-003-1304-4","volume":"48","author":"A Clark","year":"2004","unstructured":"Clark, A. et al. Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes? Diabetologia 48, 157\u2013169 (2004).","journal-title":"Diabetologia"},{"key":"54570_CR62","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1007\/s00125-010-1671-6","volume":"53","author":"S Zraika","year":"2010","unstructured":"Zraika, S. et al. Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence? Diabetologia 53, 1046\u201356 (2010).","journal-title":"Diabetologia"},{"key":"54570_CR63","doi-asserted-by":"crossref","unstructured":"Akter, R. et al. Review Article Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology. J. Diabetes Res. 2016 (2016).","DOI":"10.1155\/2016\/2798269"},{"key":"54570_CR64","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-G\u00f3mez, I. et al. Diabetes drug discovery: hIAPP1\u201337 polymorphic amyloid structures as novel therapeutic targets. Molecules 23 (2018).","DOI":"10.3390\/molecules23030686"},{"key":"54570_CR65","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1073\/pnas.1500262112","volume":"112","author":"G Wang","year":"2015","unstructured":"Wang, G. & Fersht, A. R. Propagation of aggregated p53: Cross-reaction and coaggregation vs. seeding. Proc. Natl. Acad. Sci. 112, 2443\u20132448 (2015).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"54570_CR66","doi-asserted-by":"crossref","unstructured":"Noor, H., Cao, P. & Raleigh, D. P. Morin hydrate inhibits amyloid formation by islet amyloid polypeptide and disaggregates amyloid fibers. Protein Sci. 21, 373\u2013382 (2012).","DOI":"10.1002\/pro.2023"},{"key":"54570_CR67","first-page":"1446","volume":"3","author":"M-H Aarabi","year":"2014","unstructured":"Aarabi, M.-H. et al. The ability of insulin to inhibit the formation of amyloid by pro-islet amyloid polypeptide processing intermediates is significantly reduced in the presence of sulfated. Biochemistry 3, 1446\u20131450 (2014).","journal-title":"Biochemistry"},{"key":"54570_CR68","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/bip.20853","volume":"89","author":"L Whitmore","year":"2008","unstructured":"Whitmore, L. & Wallace, B. A. Protein secondary structure analyses from circular dichroism spectroscopy: Methods and reference databases. Biopolymers 89, 392\u2013400 (2008).","journal-title":"Biopolymers"},{"key":"54570_CR69","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/nprot.2010.72","volume":"5","author":"A Jan","year":"2010","unstructured":"Jan, A., Hartley, D. M. & Lashuel, H. A. Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer\u2019s disease research. Nat. Protoc. 5, 1186\u20131209 (2010).","journal-title":"Nat. Protoc."},{"key":"54570_CR70","doi-asserted-by":"publisher","unstructured":"Wiltzius, J. E. D. J. W. et al. Atomic structure of the cross-b spine of islet amyloid polypeptide (amylin). Insulin 1467\u20131474, https:\/\/doi.org\/10.1110\/ps.036509.108.The (2008).","DOI":"10.1110\/ps.036509.108.The"},{"key":"54570_CR71","doi-asserted-by":"crossref","unstructured":"Hartl, F. U., Bracher, A. & Hayer-Hartl, M. Molecular chaperones in protein folding and proteostasis. Nature 475, 324\u2013332 (2011).","DOI":"10.1038\/nature10317"},{"key":"54570_CR72","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.1039\/C7SC00620A","volume":"8","author":"LM Young","year":"2017","unstructured":"Young, L. M., Tu, L.-H., Raleigh, D. P., Ashcroft, A. E. & Radford, S. E. Understanding co-polymerization in amyloid formation by direct observation of mixed oligomers. Chem. Sci. 8, 5030\u20135040 (2017).","journal-title":"Chem. Sci."},{"key":"54570_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40483-z","volume":"9","author":"DW Juhl","year":"2019","unstructured":"Juhl, D. W. et al. Conservation of the Amyloid Interactome Across Diverse Fibrillar Structures. Sci. Rep. 9, 3863 (2019).","journal-title":"Sci. Rep."},{"key":"54570_CR74","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1750-1326-5-57","volume":"5","author":"R Kayed","year":"2010","unstructured":"Kayed, R. et al. Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Ab oligomers. Mol. Neurodegener. 5, 57 (2010).","journal-title":"Mol. Neurodegener."},{"key":"54570_CR75","doi-asserted-by":"publisher","first-page":"7676","DOI":"10.1021\/bi3009888","volume":"51","author":"MFM Sciacca","year":"2012","unstructured":"Sciacca, M. F. M., Brender, J. R., Lee, D. K. & Ramamoorthy, A. Phosphatidylethanolamine enhances amyloid fiber-dependent membrane fragmentation. Biochemistry 51, 7676\u20137684 (2012).","journal-title":"Biochemistry"},{"key":"54570_CR76","doi-asserted-by":"publisher","first-page":"e1805166","DOI":"10.1002\/smll.201805166","volume":"15","author":"Y Sun","year":"2019","unstructured":"Sun, Y. et al. Amyloid Self-Assembly of hIAPP8-20 via the Accumulation of Helical Oligomers, \u03b1-Helix to \u03b2-Sheet Transition, and Formation of \u03b2-Barrel Intermediates. Small 15, e1805166 (2019).","journal-title":"Small"},{"key":"54570_CR77","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.scib.2018.11.012","volume":"64","author":"A Kakinen","year":"2019","unstructured":"Kakinen, A. et al. Physical and toxicological profiles of human IAPP amyloids and plaques. Sci. Bull. 64, 26\u201335 (2019).","journal-title":"Sci. Bull."},{"key":"54570_CR78","doi-asserted-by":"publisher","first-page":"6535","DOI":"10.1021\/acs.nanolett.9b02771","volume":"19","author":"A Kakinen","year":"2019","unstructured":"Kakinen, A. et al. Single-Molecular Heteroamyloidosis of Human Islet Amyloid Polypeptide. Nano Lett. 19, 6535\u20136546 (2019).","journal-title":"Nano Lett."},{"key":"54570_CR79","doi-asserted-by":"publisher","first-page":"e0135292","DOI":"10.1371\/journal.pone.0135292","volume":"10","author":"M Sabl\u00f3n-Carrazana","year":"2015","unstructured":"Sabl\u00f3n-Carrazana, M. et al. Drug Development in Conformational Diseases: A Novel Family of Chemical Chaperones that Bind and Stabilise Several Polymorphic Amyloid Structures. PLoS One 10, e0135292 (2015).","journal-title":"PLoS One"},{"key":"54570_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep19463","volume":"6","author":"P Nedumpully-Govindan","year":"2016","unstructured":"Nedumpully-Govindan, P. et al. Stabilizing Off-pathway Oligomers by Polyphenol Nanoassemblies for IAPP Aggregation Inhibition. Sci. Rep. 6, 1\u201312 (2016).","journal-title":"Sci. Rep."},{"key":"54570_CR81","doi-asserted-by":"publisher","first-page":"8452","DOI":"10.1074\/jbc.RA118.006454","volume":"294","author":"E Godin","year":"2019","unstructured":"Godin, E., Nguyen, P. T., Zottig, X. & Bourgault, S. Identification of a hinge residue controlling islet amyloid polypeptide self-assembly and cytotoxicity. J. Biol. Chem. 294, 8452\u20138463 (2019).","journal-title":"J. Biol. Chem."},{"key":"54570_CR82","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.cell.2012.02.022","volume":"148","author":"D Eisenberg","year":"2012","unstructured":"Eisenberg, D. & Jucker, M. The amyloid state of proteins in human diseases. Cell 148, 1188\u20131203 (2012).","journal-title":"Cell"},{"key":"54570_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep11811","volume":"5","author":"SA Kotler","year":"2015","unstructured":"Kotler, S. A. et al. High-resolution NMR characterization of low abundance oligomers of amyloid-\u03b2 without purification. Sci. Rep. 5, 1\u201312 (2015).","journal-title":"Sci. Rep."},{"key":"54570_CR84","doi-asserted-by":"publisher","first-page":"8154","DOI":"10.1021\/bi3012548","volume":"51","author":"Y Suzuki","year":"2012","unstructured":"Suzuki, Y., Brender, J. R., Hartman, K., Ramamoorthy, A. & Marsh, E. N. G. Alternative pathways of human islet amyloid polypeptide aggregation distinguished by (19)f nuclear magnetic resonance-detected kinetics of monomer consumption. Biochemistry 51, 8154\u201362 (2012).","journal-title":"Biochemistry"},{"issue":"2","key":"54570_CR85","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/joim.12506","volume":"280","author":"M. Ankarcrona","year":"2016","unstructured":"Ankarcrona, M. et al. Current and future treatment of amyloid diseases. J. Intern. Med., https:\/\/doi.org\/10.1111\/joim.12506 (2016).","journal-title":"Journal of Internal Medicine"},{"key":"54570_CR86","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1039\/C8SC05771K","volume":"10","author":"BR Sahoo","year":"2019","unstructured":"Sahoo, B. R. et al. A cationic polymethacrylate-copolymer acts as an agonist for \u03b2-amyloid and an antagonist for amylin fibrillation. Chem. Sci. 10, 3976\u20133986 (2019).","journal-title":"Chem. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54570-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54570-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54570-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T16:59:34Z","timestamp":1671296374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54570-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,5]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["54570"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-54570-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,5]]},"assertion":[{"value":"1 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18465"}}